QNRX [NASD]
Quoin Pharmaceuticals, Ltd.
Index- P/E- EPS (ttm)- Insider Own17.47% Shs Outstand8.35M Perf Week-15.56%
Market Cap3.16M Forward P/E- EPS next Y-13.33 Insider Trans0.00% Shs Float5.37M Perf Month-7.90%
Income-4.90M PEG- EPS next Q-3.08 Inst Own11.20% Short Float1.39% Perf Quarter-39.41%
Sales- P/S- EPS this Y- Inst Trans-1.32% Short Ratio0.05 Perf Half Y-72.64%
Book/sh267.43 P/B0.02 EPS next Y- ROA-79.70% Target Price52.03 Perf Year-97.58%
Cash/sh3.88 P/C1.22 EPS next 5Y- ROE-106.40% 52W Range3.58 - 444.00 Perf YTD-79.25%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-98.94% Beta1.66
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin- 52W Low31.84% ATR2.60
Employees4 Current Ratio3.00 Sales Q/Q- Oper. Margin- RSI (14)46.27 Volatility20.99% 50.26%
OptionableNo Debt/Eq0.12 EPS Q/Q63.80% Profit Margin- Rel Volume0.59 Prev Close4.78
ShortableYes LT Debt/Eq0.06 Earnings- Payout- Avg Volume1.47M Price4.72
Recom- SMA20-23.30% SMA50-21.20% SMA200-80.41% Volume865,818 Change-1.26%
Aug-11-22 04:30PM  
Aug-09-22 04:23PM  
Aug-05-22 09:28AM  
Jul-28-22 08:30AM  
Jul-18-22 11:43AM  
Jul-15-22 08:30AM  
07:30AM  
Jul-06-22 08:30AM  
Jun-15-22 04:01PM  
08:30AM  
Jun-14-22 08:30AM  
Jun-10-22 10:23AM  
Jun-06-22 11:22AM  
08:00AM  
May-23-22 08:30AM  
May-17-22 08:30AM  
May-11-22 11:24AM  
Apr-25-22 01:05PM  
08:30AM  
Mar-24-22 08:30AM  
Mar-15-22 08:41AM  
Mar-10-22 08:00AM  
Mar-01-22 08:00AM  
Feb-17-22 08:00AM  
Feb-10-22 08:00AM  
Feb-08-22 08:30AM  
Jan-26-22 08:00AM  
Jan-24-22 07:15AM  
Dec-15-21 09:00AM  
Dec-14-21 08:30AM  
Nov-16-21 08:30AM  
Nov-11-21 08:30AM  
Nov-08-21 08:00AM  
Nov-04-21 09:25AM  
Nov-02-21 08:30AM  
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.